Morgan Stanley Knock-Out 1FC/ DE000MG1LQ52 /
| 2024-04-30 11:59:54 AM | Chg.-0.020 | Bid12:03:24 PM | Ask12:03:24 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.640EUR | -3.03% | 0.640 Bid Size: 500 |
0.750 Ask Size: 500 |
FACC AG INH.AKT. | 5.6143 EUR | 2078-12-31 | Call |
GlobeNewswire
04-08
Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...
GlobeNewswire
04-07
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...
GlobeNewswire
04-01
Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...
GlobeNewswire
03-27
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...
GlobeNewswire
03-25
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...
GlobeNewswire
03-25
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire
03-13
Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...
GlobeNewswire
03-12
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...
GlobeNewswire
02-27
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...
GlobeNewswire
02-20
Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Hear...
GlobeNewswire
02-07
Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomat...
GlobeNewswire
01-29
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Inve...
GlobeNewswire
01-23
The International Myeloma Foundation Mourns the Passing of IMF Board Member Dr. Edith Mitchell
GlobeNewswire
2023-12-27
Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammato...
GlobeNewswire
2023-12-20
Renexxion Ireland has Completed a Successful Pre-IND Consultation with the United States FDA for Dev...
GlobeNewswire
2023-12-12
MyCardiologist Revolutionizes Heart Health Assessment & Cardiac Event Reduction with Cutting-Edge Ca...
GlobeNewswire
2023-12-05
MedBright AI Announces Election of Two US Healthcare Experts to Board of Directors and Approval of N...
GlobeNewswire
2023-11-30
Renexxion Ireland Announces Issuance of Two U.S. Patents Covering a Novel Crystal Isoform of Naronap...
GlobeNewswire
2023-11-27
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglut...
